---
title: "\"Review\" of the Hang Seng Index's Top 5 Strongest and Weakest Stocks in the First Half of 2025 (Table)"
description: "The Hang Seng Index performed strongly in the first half of 2025, with the five strongest stocks including CHOW TAI FOOK (+99.4%), Xiaomi-W (+73.8%), HANSOH PHARMA (+72.2%), SINO BIOPHARM (+64.4%), an"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/246635060.md"
published_at: "2025-06-30T09:22:47.000Z"
---

# "Review" of the Hang Seng Index's Top 5 Strongest and Weakest Stocks in the First Half of 2025 (Table)

> The Hang Seng Index performed strongly in the first half of 2025, with the five strongest stocks including CHOW TAI FOOK (+99.4%), Xiaomi-W (+73.8%), HANSOH PHARMA (+72.2%), SINO BIOPHARM (+64.4%), and Stone Pharmaceutical (+61.1%). In contrast, the five weakest stocks were BYD Electronics (-24.4%), Sands China (-21.8%), Xinyi Solar (-20.7%), Haier Smart Home (-18.4%), and Meituan-W (-17.4%). Overall, the Hang Seng Index rose by 4,012 points in the first half of 2025, an increase of 20.0%, closing at 24,072 points

Hang Seng Index's five strongest stocks in the first half of 2025:

Stock│Price Change in the First Half

CHOW TAI FOOK (01929.HK)│+99.4%

Xiaomi-W (01810.HK)│+73.8%

HANSOH PHARMA (03692.HK)│+72.2%

SINO BIOPHARM (01177.HK)│+64.4%

Stone Pharmaceutical (01093.HK)│+61.1%

Hang Seng Index's five weakest stocks in the first half of 2025:

Stock│Price Change in the First Half

BYD Electronics (00285.HK)│-24.4%

Sands China (01928.HK)│-21.8%

Xinyi Solar (00968.HK)│-20.7%

Haier Smart Home (06690.HK)│-18.4%

Meituan-W (03690.HK)│-17.4%

In summary, the Hang Seng Index rose by 4,012 points or 20.0% in the first half of 2025, closing at 24,072 points

### Related Stocks

- [01929.HK - CHOW TAI FOOK](https://longbridge.com/en/quote/01929.HK.md)
- [03692.HK - HANSOH PHARMA](https://longbridge.com/en/quote/03692.HK.md)
- [01177.HK - SINO BIOPHARM](https://longbridge.com/en/quote/01177.HK.md)
- [00285.HK - BYD ELECTRONIC](https://longbridge.com/en/quote/00285.HK.md)
- [06690.HK - HAIER SMARTHOME](https://longbridge.com/en/quote/06690.HK.md)
- [00968.HK - XINYI SOLAR](https://longbridge.com/en/quote/00968.HK.md)
- [03690.HK - MEITUAN](https://longbridge.com/en/quote/03690.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 翰森制药宣布，甲磺酸奥莫替尼片在欧盟获批用于单药治疗 | 汉森制药集团有限公司：AUMOLERTINIB 美克替尼片在欧盟作为单药治疗获得批准 | [Link](https://longbridge.com/en/news/276401882.md) |
| 早盘趋势｜中国生物制药回踩低点，反弹窗口会否开启？ | 中国生物制药（1177.HK）近期股价持续低位震荡整理，日线呈现小幅阴阳交替，整体重心下移。近几个交易日，股价回踩至前低区间附近，成交量持续萎缩，场内增量资金观望情绪浓厚。从技术面看，MACD 指标依旧死叉，绿柱显著，短线多空分歧较大。 基 | [Link](https://longbridge.com/en/news/274491341.md) |
| 早盘趋势｜中国生物制药回踩低点，反弹窗口会否开启？ | 中国生物制药（1177.HK）近期股价持续低位震荡整理，日线呈现小幅阴阳交替，整体重心下移。近几个交易日，股价回踩至前低区间附近，成交量持续萎缩，场内增量资金观望情绪浓厚。从技术面看，MACD 指标依旧死叉，绿柱显著，短线多空分歧较大。 基 | [Link](https://longbridge.com/en/news/274496124.md) |
| 早盘趋势｜中国生物制药回踩低点，反弹窗口会否开启？ | 中国生物制药（1177.HK）近期股价持续低位震荡整理，日线呈现小幅阴阳交替，整体重心下移。近几个交易日，股价回踩至前低区间附近，成交量持续萎缩，场内增量资金观望情绪浓厚。从技术面看，MACD 指标依旧死叉，绿柱显著，短线多空分歧较大。 基 | [Link](https://longbridge.com/en/news/274494597.md) |
| 早盘趋势｜中国生物制药回踩低点，反弹窗口会否开启？ | 中国生物制药（1177.HK）近期股价持续低位震荡整理，日线呈现小幅阴阳交替，整体重心下移。近几个交易日，股价回踩至前低区间附近，成交量持续萎缩，场内增量资金观望情绪浓厚。从技术面看，MACD 指标依旧死叉，绿柱显著，短线多空分歧较大。 基 | [Link](https://longbridge.com/en/news/274492204.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.